04:14 PM EST, 11/04/2025 (MT Newswires) -- Amgen ( AMGN ) reported Q3 non-GAAP net income late Tuesday of $5.64 per diluted share, up from $5.58 a year earlier

Analysts polled by FactSet expected $5.02.

Revenue for the quarter ended Sept. 30 was $9.56 billion, up from $8.50 billion a year earlier.

Analysts expected $8.97 billion.

For fiscal 2025, the company raised adjusted EPS guidance to a range of $20.60 to $21.40 from the previous range of $20.20 to $21.30. Revenue projection for the fiscal year was also raised to $35.8 billion to $36.6 billion from a range of $35 billion to $36 billion.

Analysts are looking for $21.06 and $35.67 billion, respectively.

Shares of Amgen ( AMGN ) rose 1.8% in after-hours trading.